Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEVIAC: Intra-arterial Bevacizumab and Systemic Chemotherapy in Metastatic Colorectal Cancer
NCT01677884Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- Nov 2012
- Primary completion
- Feb 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in colorectal cancer (CRC), sponsored by Gustave Roussy. Started Nov 2012; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01677884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01677884.